Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
The debate between points and cash back is ongoing. Understand the benefits of each to determine which suits you best.
28,655 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
UniCredit announces a $40 billion bid for Germany’s second-largest bank with a 4% premium, but early signals point to...
Citi sees the recent aerospace pullback as a rare entry point for Boeing, lifting the target to $260 and signaling a ...
Schd’s $71.6 billion portfolio has posted a 20% year-to-date price gain alongside a 3.3% yield, underscoring the appe...
A record M&A surge, pegged at roughly $4 trillion for 2026, is shaping the market. Wall Street is weighing whether a ...
A key Fed decision on March 18 could set the tone for inflation and, in turn, the Social Security COLA for 2027. Reti...
Bitcoin profit-taking is picking up as the bear-market rally continues. CryptoQuant reports rising on-chain profits a...
A bipartisan bill would establish a Federal Cryptocurrency Theft Task Force within the DOJ, aiming to coordinate pros...
Tesla commands a market cap near $1.5 trillion, fueling questions about whether tesla worth more than the rest of the...
As rates stay elevated and markets shift, retirees are rethinking how to fund living costs without eroding the inheri...
Block reveals a plan to slash thousands of roles with AI tools, but critics warn the move may miss broader shifts in ...
Analysts warn that grok could undermine spacex as AI bets shape risk appetite for a potential SpaceX IPO. Investors a...